Petitioner: DEPARTMENT OF HEALTH
Respondent: LAS MERCEDES DRUG STORE, INC., PH
Judges: CATHY M. SELLERS
Agency: Department of Health
Locations: Miami, Florida
Filed: Aug. 26, 2013
Status: Closed
Settled and/or Dismissed prior to entry of RO/FO on Wednesday, September 11, 2013.
Latest Update: Jan. 10, 2025
STATE OF FLORIDA
DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH,
PETITIONER,
We CASE NO. 2013-01125
LAS MERCEDES DRUG STORE, INC., PH,
RESPONDENT.
/
ADMINISTRATIVE COMPLAINT
COMES NOW, Petitioner, Department of Health, by and through its
undersigned counsel, and files this Administrative Complaint before the
Board of Pharmacy against Respondent, Las Mercedes Drug Store, Inc.,
PH, and in support thereof alleges:
1. Petitioner is the state agency charged with regulating the
practice of pharmacy pursuant to Section 20.43, Florida Statutes; Chapter
456, Florida Statutes; and Chapter 465, Florida Statutes.
2. At all _times material to this Administrative Complaint,
Respondent was a permitted community pharmacy within the state of
Florida, having been issued permit number PH 25947.
3. Respondent's address of record is 7209 SW Coral Way, Miami,
Florida 33155.
4, On or about January 9, 2013, a Department of Health
(Department) inspector conducted an inspection of Respondent at 7209
SW Coral Way, Miami, Florida 33155, and observed the following
deficiency:
| a. Pedigrees not retrievable as required by Rule 64F-
12.012(3)(a)2., (d), Florida Administrative Code,
5. On or about February 27, 2013, the Department inspector
conducted an inspection of Respondent at 7209 SW Coral Way, Miami,
Florida 33155, and observed the following deficiency:
a. Pedigrees not retrievable as required by Rule 64F-
12.012(3)(a)2., (4), Florida Administrative Code.
6. As part of the inspection on or about January 9, 2013, the
Department inspector conducted an audit of the drugs Lidoderm, Abilify,
and Advair.
7. Lidaderm is a brand name of lidocaine topical. Lidoderm is a
local anesthetic prescribed to relieve post-shingles pain.
Department af Health v. Las Mercedes Drug Store, Inc, PH
Case Number 2013-01125
8. Abilify is a brand name of aripiprazole. Abilify is an
antipsychotic medication prescribed to treat the symptoms of various
psychotic conditions.
9. Advair is a brand name of fluticasone and salmeterol. Advair
contains a steroid and a bronchodilator, and is prescribed to prevent
asthma attacks.
10. According to Respondent's purchasing records, to include
invoices and receipts, from on or about October 1, 2012 through on or
about December 31, 2012, Respondent purchased the following quantities
of the audited drugs: Lidoderm 5% patch, 30 count. Respondent was
unable to produce any purchasing records for Abilify, all strengths, or
Advair, all strengths.
11. According to Respondent's dispensing records, from on or about
October 1, 2012 through on or about December 31, 2012, Respondent
dispensed the following quantities of the audited drugs: 720 count of
Lidaderm 5% patch, 180 tablets of Abilify, all strengths, and.960 tablets.of
Advair, all strengths.
12. From on or about October 1, 2012 through on or about
December 31, 2012, Respondent cannot provide documentation to account
Department of Health v. Las Mercedes Drug Store, Inc., PH 3
Case Number 2013-01125
for the receipt of 690 count of Lidoderm 5% patch, and/or 180 tablets of
Abilify, all strengths, and/or 960 tablets of Advair, all strengths, ,
13. As part of the inspection on or about February 27, 2013, the
Department inspector conducted an audit of the drug Crestor.
14. Crestor is a brand name of rosuvastatin. Crestor is a statin
prescribed to lower cholesteral in the blood.
15. According to Respondent's purchasing records, to include
invoices and receipts, from on or about January 1, 2013 through on or
about February 27, 2013, Respondent purchased 90 tablets of Crestor, 20
milligrams. .
16. According to Respondent’s dispensing records, from on or about
January 1, 2013 through on or about February 27, 2013, Respondent
dispensed 390 tablets of Crestor, 20 milligrams.
17, From on or about January 1, 2013 through on or about
February 27, 2013, Respondent cannot provide documentation to account
for the receipt of approximately 300 tablets of Crestor, 20 milligrams.
18. Section 465.023(1)(c), Florida Statutes (2012), provides that
the board may revoke or suspend the permit of any pharmacy permittee,
and may fine, place on probation, or otherwise discipline any pharmacy
Department of Health v. Las Mercedes Drug Store, Inc, PH 4
Case Number 2013-01125
permittee who has violated any of the requirements of Chapter 499, Florida
Statutes (2012), or any of the rules of the Board of Pharmacy.
19. Section 499.005(18}, Florida Statutes (2012), states that it is
unlawful if there is a failure to maintain records as required by this part and
rules adopted under this part.
20, Rule 61N-1.012(1)(a), Florida Administrative Code, (formerly
Rule 64F-12.012(1}(a), FA.C.), provides that records to document the
movement of drugs, devices or cosmetics must provide a complete audit
trail from a person's receipt or acquisition to sale or other disposition of the
product or component.
21. As set forth in paragraph twelve, on or about January 9, 2013,
the Department inspector found Respondent unable to retrieve the
pedigree records or invoices for 690 count of Lidoderm 5% patch, and/or
180 tablets of Abilify, all strengths, and/or 960 tablets of Advair, all
strengths.
22. As set forth in paragraph seventeen, on or about February 27,
2013, the Department inspector found Respondent unable to retrieve the
pedigree records or invoices for 300 tablets of Crestor, 20 milligrams.
Department of Health v, Las Mercedes Drug Store, Inc., PH 5
Case Number 2013-01125
23. Based on the foregoing, Respondent has violated Section
465.023(1)(c), Florida Statutes (2012), by violating Section 499.005(18),
Florida Statutes (2012), by violating Rule G1N-1.012(1){a), Florida
Administrative Code, which requires that records to document the
movement of drugs, devices or cosmetics must provide a complete audit
trall from a person’s receipt or acquisition to sale or other disposition of the
product or component.
WHEREFORE, the Petitioner respectfully requests that the Board of
Pharmacy enter an order imposing one or more of the following penalties:
permanent revocation or suspension of Respondent’s license, restriction of
practice, imposition of an administrative fine, issuance of a reprimand,
placement of the Respondent on probation, corrective action, refund of
fees billed or collected, remedial education and/or any other relief that the
Board deems appropriate.
SIGNED this _20* day of DUNE 2013.
John H. Armstrong, MD, FACS
State Surgeon General and Secretary of Health
Department of Health v, Las Mercedes Drug Store, Inc., PH 6
Case Number 2013-01125
Chelan. A _fessite
CHRISTOPHER A.J CH
Assistant General Counsel
Fla. Bar No. 0099014
FILED Florida Department of Health
DEPARTMENT OFHEALTH Office of the General Counsel
CLERK Angel sannnn 4052 Bald Cypress Way, Bin #C65
pare JUN S 3G Tallahassee, FL 32399-3265
“ Telephone: (850) 245-4444 ext. 8174
Facsimile: (850) 245-4683
Email: christopher_jurich@doh. state. fl.us
{CAJ
PCP: June 20,0015
PCP Members: Mesaros, J. + Risch) L.
Department of Health v. Las Mercedes Drug Store, Inc, PH
Case Number 2013-01125
NOTICE OF RIGHTS
Respondent has the right to request a hearing to be
conducted in accordance with Section 126.569 and 120.57,
Florida Statutes, to be represented by counsel or other qualified
representative, to present evidence and argument, to call and
cross-examine witnesses and to have subpoena and subpoena
duces tecum issued on his or her behalf if a hearing is requested.
NOTICE REGARDING ASSESSMENT OF COSTS
Respondent is placed on notice that Petitioner has incurred
costs related to the investigation and prosecution of this matter.
Pursuant to Section 456.072(4), Florida Statutes, the Board shall
assess costs related to the investigation and prosecution of a
disciplinary matter, which may include attorney hours and costs,
on the Respondent in addition to any other discipline imposed.
Department of Health v. Las Mercedes Drug Store, Inc., PH 8
Cease Number 2013-01125
Docket for Case No: 13-003258
Issue Date |
Proceedings |
Sep. 11, 2013 |
Order Closing File and Relinquishing Jurisdiction. CASE CLOSED.
|
Sep. 11, 2013 |
Motion to Relinquish Jurisdiction filed.
|
Sep. 04, 2013 |
Order of Pre-hearing Instructions.
|
Sep. 04, 2013 |
Notice of Hearing by Video Teleconference (hearing set for October 25, 2013; 9:00 a.m.; Miami and Tallahassee, FL).
|
Sep. 03, 2013 |
Unilateral Response to Initial Order filed.
|
Aug. 27, 2013 |
Notice of Serving Petitioner's First Request for Admissions, Interrogatories, and Production of Documents filed.
|
Aug. 27, 2013 |
Notice of Appearance (Jodi-Ann V. Johnson) filed.
|
Aug. 27, 2013 |
Initial Order.
|
Aug. 26, 2013 |
Notice of Appearance (filed by C. Jurich).
|
Aug. 26, 2013 |
Administrative Complaint filed.
|
Aug. 26, 2013 |
Election of Rights filed.
|
Aug. 26, 2013 |
Agency referral filed.
|